An oncology hospital partners with an AI company to share its data with doctors worldwide

{
  "signal_id": "013d1937-de5a-891a-15ec-0d078cb0240d",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-09-24T14:27:00+00:00",
  "company": {
    "name": "OpenEvidence",
    "domain": "openevidence.com"
  },
  "data": {
    "url": "https://curecompass.com.ar/un-hospital-oncologico-se-asocia-con-una-empresa-de-ia-para-compartir-sus-datos-con-medicos-de-todo-el-mundo/",
    "title": "An oncology hospital partners with an AI company to share its data with doctors worldwide - CureCompass",
    "excerpt": "OpenEvidence and Memorial Sloan Kettering Cancer Center (MSK) announced an alliance to bring precision oncology decision support to more healthcare professionals. The agreement integrates OncoKB, the genomic knowledge base curated by MSK specialists, into OpenEvidence's clinical artificial intelligence platform and the Epic electronic health record environment used by the cancer center. The integration seeks to help doctors interpret genetic alterations detected in tumors, show if they act as clinically relevant biomarkers, and associate them with available evidence and therapies. OpenEvidence already incorporated treatment guidelines from the National Comprehensive Cancer Network (NCCN) and recommendations, figures, and algorithms from the American Society of Clinical Oncology (ASCO).\nOncoKB is a precision oncology knowledge base developed by MSK. Its function is to offer evidence-based evaluations on whether a genetic alteration identified in a tumor can act as a clinically actionable biomarker and guide subsequent therapeutic decisions. As a result of the alliance, MSK-curated annotations will be visible within OpenEvidence and Epic, along with the patient's clinical context. When a professional consults a specific genomic alteration, they will be able to access MSK's expert evaluation of its clinical relevance, the level of available evidence, and therapies linked to that...",
    "summary": "OpenEvidence and Memorial Sloan Kettering Cancer Center (MSK) have formed an alliance to integrate MSK's OncoKB genomic knowledge base into OpenEvidence's clinical AI platform.",
    "planning": true,
    "image_url": "https://curecompass.com.ar/wp-content/uploads/2026/09/oncokb.jpg",
    "confidence": 0.9,
    "published_at": "2026-09-24T14:27:00Z",
    "article_sentence": "OpenEvidence and Memorial Sloan Kettering Cancer Center (MSK) announced an alliance to bring precision oncology decision support to more healthcare professionals.",
    "related_company_name": "Memorial Sloan Kettering Cancer Center",
    "related_company_domain": "mskcc.org"
  }
}

curl https://signals.autobound.ai/v1/signals/013d1937-de5a-891a-15ec-0d078cb0240d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"openevidence.com","limit":20}'